MTCM
GNMK

Mint Tower Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Mint Tower Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-41,230
Closed -$985K – 448
2021
Q1 		$985K Buy
+41,230
New +$766K 0.09% 171

Mint Tower Capital Management's GNMK Position: Q2 2021 in Review

Mint Tower Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 41,230 shares — an estimated $985K sold.

Mint Tower Capital Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $985K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • Mint Tower Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • Mint Tower Capital Management sold 41,230 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $985K.
  • Mint Tower Capital Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • Mint Tower Capital Management's GenMark Diagnostics, Inc position peaked at $985K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Mint Tower Capital Management's 13F filing for Q2 2021, filed 2 Aug 2021.